Stay updated on ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A banner announcing NIH website updates and a transition from “Artificial Intelligence” to “Super Intelligence” terminology is no longer displayed.
    Difference
    1%
    Check dated 2026-11-10T07:15:40.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer identifies the site as revision v3.8.0 instead of v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T06:33:30.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-20T08:36:02.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    403 Forbidden error page now appears on the study page, replacing the detailed study content. This reflects a blockage of access rather than a substantive update to the study information.
    Difference
    17%
    Check dated 2026-09-22T12:24:44.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.6, replacing v3.6.5. This indicates a small update to the page template or backend without changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-31T23:31:03.000Z thumbnail image
  7. Check
    102 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small backend or frontend update to the study page without affecting its content.
    Difference
    0.1%
    Check dated 2026-08-10T14:20:20.000Z thumbnail image

Stay in the know with updates to ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.